Publication:
Long-Term Effect of Interferon Therapy in Patients with HBeAg Positive Chronic Hepatitis B Infection

Placeholder

Organizational Units

Program

Authors

Senturk, HAKAN
Baysal, Birol
Tahan, Veysel
Zerdali, Hasan
Ozaras, Resat
Tabak, Fehmi
Mert, Ali
Canbakan, Billur
Tabak, Omur
Ozbay, Gulsen

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Introduction Several studies have reported that interferon therapy increases elimination rate of HBeAg and anti-HBe seroconversion in chronic hepatitis B (CHB) patients. We aimed to evaluate long-term results of interferon-alpha treatment in HBeAg positive CHB patients in a country with exclusively D genotype.

Description

Source:

Keywords:

Keywords

Citation

Senturk H., Baysal B., Tahan V., Zerdali H., Ozaras R., Tabak F., Mert A., Canbakan B., Tabak O., Ozbay G., -Long-Term Effect of Interferon Therapy in Patients with HBeAg Positive Chronic Hepatitis B Infection-, DIGESTIVE DISEASES AND SCIENCES, cilt.56, ss.208-212, 2011

Collections

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals

Thumbnail Image
Goal